Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,431,207,652
-$160,899,839 QoQ
Shares Held
18,095,178
-0.7% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#11
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $23,952,609,496 across 9 Drug Manufacturers - General names. AZN ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,172,904 | $11,002,257,162 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
18,095,178 | $3,431,207,652 | |
| 3 | BIIB |
Biogen Inc.
|
15,154,606 | $3,274,304,172 | |
| 4 | AMGN |
Amgen Inc
|
6,756,962 | $2,446,831,079 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,923,900 | $1,436,115,118 | |
| 6 | GSK |
GSK plc
|
25,182,068 | $1,320,044,004 | |
| 7 | NVS |
Novartis AG
|
6,592,124 | $1,033,117,673 | |
| 8 | MRK |
Merck & Co., Inc.
|
35,700 | $4,587,450 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,431,207,652 | 18,095,178 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,592,107,491 | 18,213,708 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||